Literature DB >> 11912024

HIV proteinase inhibitors: do they really work against Candida in a clinical setting?

Antonio Cassone1, Roberto Cauda.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11912024     DOI： 10.1016/s0966-842x(02)02341-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  7 in total

1.  Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women.

Authors:  Mariceli Araujo Ribeiro; Angelica Espinosa Miranda; Walderez Gambale; Claudete Rodrigues Paula
Journal:  Mycopathologia       Date:  2004-04       Impact factor: 2.574

2.  In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.

Authors:  Francesca Mondello; Flavia De Bernardis; Antonietta Girolamo; Antonio Cassone; Giuseppe Salvatore
Journal:  BMC Infect Dis       Date:  2006-11-03       Impact factor: 3.090

3.  HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites.

Authors:  Rhian E White; David J Powell; Colin Berry
Journal:  FASEB J       Date:  2011-01-25       Impact factor: 5.191

4.  Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches.

Authors:  André L S Santos; Lys A Braga-Silva; Diego S Gonçalves; Lívia S Ramos; Simone S C Oliveira; Lucieri O P Souza; Vanessa S Oliveira; Roberto D Lins; Marcia R Pinto; Julian E Muñoz; Carlos P Taborda; Marta H Branquinha
Journal:  J Fungi (Basel)       Date:  2021-05-28

5.  Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.

Authors:  Livia Di Trani; Andrea Savarino; Laura Campitelli; Sandro Norelli; Simona Puzelli; Daniela D'Ostilio; Edoardo Vignolo; Isabella Donatelli; Antonio Cassone
Journal:  Virol J       Date:  2007-05-03       Impact factor: 4.099

6.  Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.

Authors:  Andrea Savarino; Mauro Pistello; Daniela D'Ostilio; Elisa Zabogli; Fabiana Taglia; Fabiola Mancini; Stefania Ferro; Donatella Matteucci; Laura De Luca; Maria Letizia Barreca; Alessandra Ciervo; Alba Chimirri; Massimo Ciccozzi; Mauro Bendinelli
Journal:  Retrovirology       Date:  2007-10-30       Impact factor: 4.602

7.  Global Identification of Biofilm-Specific Proteolysis in Candida albicans.

Authors:  Michael B Winter; Eugenia C Salcedo; Matthew B Lohse; Nairi Hartooni; Megha Gulati; Hiram Sanchez; Julie Takagi; Bernhard Hube; David R Andes; Alexander D Johnson; Charles S Craik; Clarissa J Nobile
Journal:  mBio       Date:  2016-09-13       Impact factor: 7.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.